Retrospective Assessment of AE-Related Healthcare Resource Utilization and Costs of Immune Checkpoint Inhibitor and Targeted Therapy for Adjuvant Treatment of Melanoma
Clinical trial NCT05874817 · COMPLETED
Trial details
- NCT number
- NCT05874817
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2021-05-01
- Primary completion
- 2022-05-20
- Enrollment
- 17517
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.